文献速递关节外科脊柱外科

问题在于阿片类药物而非脊柱外科医生:全髋关节置换术后脱位与既往腰椎融合患者的阿片类药物使用相关

It is the Opioids Not the Spine Surgeon; Dislocation After Total Hip Arthroplasty is Associated With Opioid Use in Patients Who Have Prior Lumbar Spine Fusion.
PubMed 文献 · J Arthroplasty · 2023-03-06

该回顾性研究利用2012至2019年全国数据库246,617例初次和34,083例翻修全髋关节置换(THA)病例,其中1,903例初次和288例翻修THA有既往腰椎融合(LSF)。多因素分析显示,在既往LSF患者中,THA时使用阿片类药物与初次(aOR=2.29,95%CI 1.46-3.57,P<.0003)和翻修THA(aOR=1.92,95%CI 1.62-3.08,P<.0003)脱位风险增加相关。作者认为脱位风险是多因素的,应寻求减少THA前阿片类药物使用的策略。

要点

  • 既往腰椎融合患者THA时使用阿片类药物,初次THA脱位aOR=2.29(95%CI 1.46-3.57,P<.0003)。
  • 既往腰椎融合患者THA时使用阿片类药物,翻修THA脱位aOR=1.92(95%CI 1.62-3.08,P<.0003)。
  • 无阿片使用的既往腰椎融合与脱位aOR=1.38(95%CI 1.01-1.88,P=.04),低于无腰椎融合但使用阿片类的aOR=1.72(95%CI 1.63-1.81,P<.001)。

核心结论

  • 在既往腰椎融合患者中,THA时使用阿片类药物与脱位风险增加相关;阿片类药物使用相关的脱位风险高于既往腰椎融合本身。
  • 作者认为脱位风险是多因素的,应寻求减少THA前阿片类药物使用的策略。

研究设计与样本

  • 回顾性研究,使用大型全国数据库,纳入2012年至2019年246,617例初次THA和34,083例翻修THA病例。
  • 其中1,903例初次THA和288例翻修THA在THA前有腰椎融合。
  • 主要结局为术后髋关节脱位,患者按THA时是否使用阿片类药物分层,收集年龄、性别和肥胖等人口学数据,多因素分析调整人口学因素后评估阿片使用与脱位的关联。

主要发现

  • 在既往腰椎融合患者中,THA时使用阿片类药物与初次THA脱位风险增加相关(aOR=2.29,95%CI 1.46-3.57,P<.0003)。
  • 在既往腰椎融合患者中,THA时使用阿片类药物与翻修THA脱位风险增加相关(aOR=1.92,95%CI 1.62-3.08,P<.0003)。
  • 无阿片使用的既往腰椎融合与脱位风险增加相关(aOR=1.38,95%CI 1.01-1.88,P=.04),但低于无腰椎融合但使用阿片类的风险(aOR=1.72,95%CI 1.63-1.81,P<.001)。

临床怎么用

  • 作者认为应寻求减少THA前阿片类药物使用的策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients who have prior lumbar spine fusion (LSF) have an increased risk for dislocation after total hip arthroplasty (THA). These patients also have elevated rates of opioid use. We aimed to evaluate the associated risk of dislocation after THA in patients who have prior LSF comparing those who have opioid use to those who do not. METHODS: This was a retrospective review using a large national database of 246,617 primary and 34,083 revision THA cases from 2012 to 2019. There were 1,903 primary THA and 288 revision THA cases identified with LSF prior to THA. Postoperative hip dislocation was our primary outcome variable and patients were stratified to use or nonuse of opioid at THA. Demographic data including age, sex, and obesity were collected. Multivariate analyses evaluated association of opioid use and dislocation after adjusting for demographics. RESULTS: There was increased odds of dislocation for opioid use at THA for both primary (adjusted Odds Ratio [aOR] = 2.29, 95% Confidence Interval [CI] 1.46 to 3.57, P < .0003) and revision THA (aOR = 1.92, 95% CI 1.62 to 3.08, P < .0003), in patients who have prior LSF. Prior LSF without opioid use was associated with increased odds of dislocation (aOR = 1.38, 95% CI 1.01 to 1.88, P = .04), but this was lower than the associated risk of opioid use without LSF (aOR 1.72, 95% CI 1.63 to 1.81, P < .001). CONCLUSION: Increased odds of dislocation were noted with opioid use at time of THA in patients who have prior LSF. Associated risk of dislocation was higher for opioid use than prior LSF. This suggests that dislocation risk is multifactorial and we should look to strategies to reduce opioid use prior to THA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kagan R, Welling S, Mildren ME, et al. It is the Opioids Not the Spine Surgeon; Dislocation After Total Hip Arthroplasty is Associated With Opioid Use in Patients Who Have Prior Lumbar Spine Fusion. J Arthroplasty. 2023. PMID: 36889529. doi:10.1016/j.arth.2023.02.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。